Contracts show Valeant's bonuses offer to pharmacy
Documents provide new insights into relationship at the heart of drug maker's share meltdown
Wed, May 11, 2016 - 5:50 AM
The company was the subject of hours of US Senate testimony in April, which included appearances by Mr Pearson (front, right), Valeant's former chief executive.
EMBATTLED drug maker Valeant Pharmaceuticals International offered tens of millions of dollars in incentives to a pharmacy to sell its products even as the relationship between the two was kept private, according to documents released by a Senate committee.